Drugs / Pentostam
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03009422 | Nov 2014 → Feb 2017 | leishmaniasis | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pentostam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03009422 ↗ |
| Route | Topical | “topical application of Pentostam” NCT03009422 ↗ |